Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Pharmacological Reviews
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Pharmacological Reviews

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit Pharm Rev on Facebook
  • Follow Pharm Rev on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

September 01, 2006; Volume 58,Issue 3

IUPHAR Nomenclature Report

  • You have access
    International Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to Therapy
    Maria P. Abbracchio, Geoffrey Burnstock, Jean-Marie Boeynaems, Eric A. Barnard, José L. Boyer, Charles Kennedy, Gillian E. Knight, Marta Fumagalli, Christian Gachet, Kenneth A. Jacobson and Gary A. Weisman
    Pharmacological Reviews September 2006, 58 (3) 281-341; DOI: https://doi.org/10.1124/pr.58.3.3

Review Articles

  • You have access
    Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
    Anatol Kontush and M. John Chapman
    Pharmacological Reviews September 2006, 58 (3) 342-374; DOI: https://doi.org/10.1124/pr.58.3.1
  • You have access
    Eicosanoid Transcellular Biosynthesis: From Cell-Cell Interactions to in Vivo Tissue Responses
    Giancarlo Folco and Robert C. Murphy
    Pharmacological Reviews September 2006, 58 (3) 375-388; DOI: https://doi.org/10.1124/pr.58.3.8
  • You have access
    The Endocannabinoid System as an Emerging Target of Pharmacotherapy
    Pál Pacher, Sándor Bátkai and George Kunos
    Pharmacological Reviews September 2006, 58 (3) 389-462; DOI: https://doi.org/10.1124/pr.58.3.2
  • You have access
    The Lipoxin Receptor ALX: Potent Ligand-Specific and Stereoselective Actions in Vivo
    Nan Chiang, Charles N. Serhan, Sven-Erik Dahlén, Jeffrey M. Drazen, Douglas W. P. Hay, G. Enrico Rovati, Takao Shimizu, Takehiko Yokomizo and Charles Brink
    Pharmacological Reviews September 2006, 58 (3) 463-487; DOI: https://doi.org/10.1124/pr.58.3.4
  • You have access
    Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use
    Andrew T. Bender and Joseph A. Beavo
    Pharmacological Reviews September 2006, 58 (3) 488-520; DOI: https://doi.org/10.1124/pr.58.3.5
  • You have access
    Pharmacogenetics, Drug-Metabolizing Enzymes, and Clinical Practice
    Sharon J. Gardiner and Evan J. Begg
    Pharmacological Reviews September 2006, 58 (3) 521-590; DOI: https://doi.org/10.1124/pr.58.3.6
  • You have access
    Inhibitors of Brain Phospholipase A2 Activity: Their Neuropharmacological Effects and Therapeutic Importance for the Treatment of Neurologic Disorders
    Akhlaq A. Farooqui, Wei-Yi Ong and Lloyd A. Horrocks
    Pharmacological Reviews September 2006, 58 (3) 591-620; DOI: https://doi.org/10.1124/pr.58.3.7
  • You have access
    Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
    Ting-Chao Chou
    Pharmacological Reviews September 2006, 58 (3) 621-681; DOI: https://doi.org/10.1124/pr.58.3.10

Erratum

  • You have access
    Correction to “Therapeutic Targets: Progress of Their Exploration and Investigation of Their Characteristics”
    Pharmacological Reviews September 2006, 58 (3) 682;
Back to top
PreviousNext

In this issue

Pharmacological Reviews: 58 (3)
Pharmacological Reviews
Vol. 58, Issue 3
1 Sep 2006
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • IUPHAR Nomenclature Report
  • Review Articles
  • Erratum
  • Most Cited
  • Most Read
Loading
  • Nitric oxide: physiology, pathophysiology, and pharmacology.
  • The Glutamate Receptor Ion Channels
  • Receptors for Purines and Pyrimidines
  • Evolving Concepts in G Protein-Coupled Receptor Endocytosis: The Role in Receptor Desensitization and Signaling
  • Glutamate Receptor Ion Channels: Structure, Regulation, and Function
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Pharmacological Reviews
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacology Research & Perspectives
ISSN 1521-0081 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics